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ABSTRACT  1 
Several molecules have been exploited for developing MRI pH sensors based on the chemical 2 
exchange saturation transfer (CEST) technique. A ratiometric approach, based on the saturation of 3 
two exchanging pools at the same saturation power, or by varying the saturation power levels on the 4 
same pool, is usually needed to rule out the concentration term from the pH measurement. However, 5 
all these methods have been demonstrated by using a continuous wave saturation scheme that limits 6 
its translation to clinical scanners. This study shows a new ratiometric CEST-MRI pH-mapping 7 
approach based on a pulsed CEST saturation scheme for a radiographic contrast agent (iodixanol) 8 
possessing a single chemical exchange site. This approach is based on the ratio of the CEST contrast 9 
effects at two different flip angles combinations (180°/360° and 180°/720°), keeping constant the 10 
mean irradiation RF power (Bavg power). The proposed ratiometric approach index is concentration 11 
independent and it showed good pH sensitivity and accuracy in the physiological range between 6.0 12 
and 7.4. 13 
 14 
Keywords: CEST; MRI; pH; iodinated contrast media; train pulses; pulsed-CEST; contrast 15 
media; radiographic agents; 16 
 17 
Highlights: 18 
• A novel ratiometric approach based on a pulsed saturation scheme is proposed 19 
• This approach can be applied to molecules possessing a single proton pool 20 
• A good pH accuracy can be obtained in the physiological range (pH 6.0-7.4) 21 
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1. Introduction 1 
Chemical Exchange Saturation Transfer (CEST) is an innovative MRI contrast mechanism that can 2 
detect molecules with exchangeable protons upon saturation with selective radiofrequency pulses [1-3 
3]. Exchanging proton pools include endogenous protons (amide, hydroxyls), as well as exogenous 4 
ones belonging to added diamagnetic or paramagnetic agents [4-13]. Several applications have been 5 
reported, including the assessment of ischemic acidosis [14], tumor detection [4, 15, 16], cell tracking 6 
[17-19], proteins structural properties [20-22], metabolites [23, 24], redox potential [25, 26], gene 7 
expression [27, 28] and enzymatic activity [29]. In particular, great attention has been dedicated to 8 
design agents able to map tissue pH [30-33]. In this context, a good example is represented by 9 
iopamidol, a clinical approved x-ray contrast agent possessing two types of amide protons whose 10 
different exchange rate has been exploited to set up a ratiometric approach for imaging tissue pH [34-11 
37]. Similar results have been obtained with the related iopromide agent [38] or with imidazole-based 12 
pH sensors [39]. The above method relies on the presence of two exchangeable pools in order to 13 
exploit the ratiometric approach for a concentration independent measure of pH [40]. Recently, 14 
another x-ray agent containing only one mobile amide proton pool, iobitridol, was used to image 15 
tumor pH in vivo by ratioing the CEST effects resulting from the application of radiofrequency (RF) 16 
pulses of different power [41]. In general, the reported CEST studies relied on the application of a 17 
continuous wave (CW) irradiation scheme, consisting of a long off-resonance rectangular RF 18 
irradiation pulse. A major drawback of this irradiation scheme is represented by the high specific 19 
absorption rate (SAR) that limit the translation of the preclinical procedures to commercial human 20 
MRI scanners. Conversely, the pulsed-CEST imaging scheme addresses the hardware and SAR 21 
concerns by exploiting repetitive short RF pulses as irradiation scheme [42-49]. This saturation 22 
scheme is commonly applied at clinical level for amide proton transfer imaging [50-53]. Recent 23 
studies have shown that pulsed CEST contrast comprises both saturation and rotation effects (arising 24 
from an oscillating component). Consequently, the repeated rotation of the spin magnetization 25 
provides a complementary contribution to the decrease of the bulk water signal following the 26 
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chemical exchange [54]. This separation of rotation vs saturation transfer-effects in pulsed CEST 1 
experiments was dubbed chemical exchange rotation transfer (CERT). Moreover, it was found that 2 
pulsed CEST contrast as a function of the flip angle (θ) is dependent on the chemical exchange rate 3 
(kex) of the exchanging mobile proton pool. Gochberg and colleagues have exploited these properties 4 
using the ratio of contrast at multiple θ values for assessing chemical exchange rate of endogenous 5 
amide and amine protons by keeping constant the transmitted B1 amplitudes (Bavg power) at different 6 
flip angles [55]. 7 
Here, we demonstrate the application of a double-angle ratiometric approach on the clinical approved 8 
x-ray contrast agent, iodixanol, possessing only one amide proton pool (Fig. 1), for the generation of 9 
a new pH-responsive CERT contrast agent. The proposed method, called ratio of pulsed RF angles 10 
(RPA), is based on the ratio of CERT contrast at two different θ values by keeping Bavg power constant. 11 
The influence of different Bavg power levels, duty cycle, temperature, concentration and θ values under 12 
a pulsed CEST sequences was also evaluated. 13 
 14 
2. Materials and Methods  15 
2.1 Numerical Simulation 16 
Simulated pulsed CEST-MRI was generated using Matlab (Mathworks, Natick, MA, USA) using the 17 
modified Bloch-McConnell equations [45, 56, 57] for a three pool model (water, hydroxyl and amide 18 
protons labeled as w, b and s, respectively) with a field strength of 7T. Pulsed saturation was modeled 19 
using the discretization method, with each Gaussian pulse divided into 64 steps and the spin evolution 20 
was modeled assuming a constant B1 amplitude within each step. The transverse magnetization was 21 
set to zero at the end of the inter-pulse period to represent the dephasing caused by crusher gradients, 22 
whereas the longitudinal magnetization relaxed toward equilibrium [44]. 23 
The variables in the model were set according to the range of values calculated from fitting Z-spectra 24 
obtained from phantom #1 (40 mM iodixanol in phosphate buffer solutions titrated in the pH range 25 
5.5-7.9) at 37°C with CW saturation at several irradiation powers (1, 2 and 3 µT for 5s) in the range 26 
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±10 ppm with steps of 0.1 ppm. Specifically, the following variables were fixed to previously 1 
published values [58, 59]: longitudinal relaxation time, T1w= 4.0s, T1b = 1.0s, T1s= 1.0s; T2w = 1.5s, 2 
T2b = 0.8s, chemical shift ωb = 0.8 ppm, ωs =4.3 ppm; or to experimental conditions: amide proton 3 
ratio (fs) = 0.00145 (40mM*4/110M), hydroxyl proton ratio (fb) = 0.0033 (40mM*9/110M). The 4 
following parameters were solved from numerical fitting: exchange rates for amide (kex) and hydroxyl 5 
groups (kwb) and T2s for each pH value. 6 
A range of parameter values were simulated for pulsed CEST-MRI: FA (θ) varied from 45° to 900° 7 
with intervals of 15°, T1w (3.0-3.7-4.4 s), T2w (1.5-2.0-2.5 s), T1s (1.0-2.0-3.0 s), T2s (10-20-30 ms), 8 
fs (0.007-0.0011-0.0018), kex (21-47-108-150 Hz), dc was set at 30% and 50%. 9 
 10 
2.2 In vitro 11 
2.2.1 Phantom Preparation 12 
Three sets of phantoms were prepared by dissolving iodixanol (Visipaque®, GE Healthcare) in 13 
different media. A phantom containing several vials of 40 mM iodixanol in phosphate buffered 14 
solution were pH titrated between 5.5 and 7.9 and used for calculating the chemical exchange rates 15 
under CW irradiation and for the CERT experiments under Gaussian-train irradiation scheme. A 16 
second phantom was prepared by dissolving iodixanol in phosphate buffer solution at pH = 7.2 at 17 
different concentrations (2.5-5.0-10.0-20.0-40.0 mM) to investigate the concentration independence 18 
of the proposed ratiometric approach. A third phantom was prepared by dissolving 40 mM iodixanol 19 
in reconstituted human plasma (Seronorm Human, SERO AS ASKER, Norway) at several pH values 20 
(6.3, 6.7, 7.0, 7.4) to mimic in vivo conditions with the presence of several proteins and metabolites 21 
at physiological concentrations. 22 
 23 
2.2.2 Magnetic Resonance Imaging  24 
Pulsed-CEST experiments were acquired on a 7T Bruker Avance 300 scanner (Bruker BioSpin, 25 
Ettlingen, Germany) equipped with a micro 2.5 MICWB 30 mm quadrature (1H) imaging probe. Z-26 
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spectra were acquired sampling the frequency offsets from -10 ppm to 10 ppm, with step size of 0.1 1 
ppm. The pulsed-CEST scheme exploited a series of Gaussian irradiation pulses for the saturation 2 
part and a single-shot (with centric encoding) fast spin-echo imaging readout. After each pulse, 3 
crusher gradients (with alternating sign) were applied to spoil residual transverse magnetization. Each 4 
irradiation pulse had duration τP, flip angle θ, interpulse delay τD and the pulse train repetition (PTR) 5 
is given by τP + τD. Bavg power levels were set to be 0.5, 1.0 and 2.0 µT with different values of duty 6 
cycle (dc) of 50% and 30% for a total irradiation time of 5 s. To test the predicted angular dependence, 7 
15 values between 45 and 900° were acquired for each Bavg power level and dc conditions. 8 
For pulsed-CEST imaging, Bavg power can be calculated by using the following equation [60]: 9 
 10 
𝐵𝐵𝑎𝑎𝑎𝑎𝑎𝑎 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 = � 1𝑃𝑃𝑃𝑃𝑃𝑃 ∫ 𝐵𝐵12𝑑𝑑𝑑𝑑𝑃𝑃𝑃𝑃𝑃𝑃0 = �𝑝𝑝2𝑑𝑑𝑑𝑑  ∙ 𝜋𝜋𝜋𝜋180∙𝛾𝛾∙𝑝𝑝1∙𝑃𝑃𝑃𝑃𝑃𝑃 [1] 11 
 12 
Where Bavg power is the field strength of a continuous wave irradiation with the same average power as 13 
the pulsed-CEST, p1 is the ratio of the average amplitude to the maximum amplitude of the irradiation 14 
pulse, p2 is the ratio of the average of the square of the amplitude to the square of the maximum 15 
amplitude of the irradiation pulse and γ is the gyromagnetic ratio of the proton (with units rad s-1 T-16 
1). For the Gaussian pulse used in our experiments p1 and p2 are equal to 0.418 and 0.299, respectively.  17 
Images were acquired with the following parameters: field of view = 30 mm x 30 mm, matrix size = 18 
64 x 64, slice thickness = 4 mm, echo time = 3.5 ms, repetition time = 10 s, two averages. The 19 
experiments were performed at 21±1 °C and at 37±1 °C. 20 
 21 
2.2.3 CEST image analysis 22 
All Z-spectra were analyzed using custom-written scripts in Matlab (Mathworks, Natick, MA, USA) 23 
and interpolated by smoothing splines for B0 inhomonogeneity correction [61]. CEST contrast named 24 
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Saturation Transfer (ST) was quantified at a specific offset of interest (i.e. Δω= +4.3 ppm) using the 1 
asymmetry analysis: 2 
𝑆𝑆𝑆𝑆 = 𝑆𝑆−Δ𝜔𝜔−𝑆𝑆+Δ𝜔𝜔
𝑆𝑆0
 [2] 3 
Where S±Δω is the water signal intensity in the presence of a saturation pulse at offset ±Δω and S0 is 4 
water signal intensity in the absence of a saturation pulse. 5 
A new ratiometric index (dubbed ratio of pulsed RF angles or RPA) is calculated as the ratio of the 6 
CEST ST contrast at two θ values according to equation 3: 7 
𝑅𝑅𝑅𝑅𝑅𝑅 = 𝑆𝑆𝑃𝑃𝜃𝜃1
𝑆𝑆𝑃𝑃𝜃𝜃2
  [3] 8 
where STθ1,2 represents ST obtained at two selected flip angles (θ1 and θ2) by keeping Bavg power 9 
constant.  10 
 11 
3. Results 12 
Z-spectra were acquired with CW irradiation on 40 mM iodixanol samples at several pH values (5.5-13 
7.9) and fit to a three-pool exchange model by simultaneously fitting three different B1 irradiation 14 
powers (Fig. S1), giving exchange rates for the amide mobile protons in the range 10 to 850 Hz (Table 15 
S1).   16 
Fig. 2 show the simulated CEST contrast for a 40 mM iodixanol solution as a function of θ, showing 17 
the amide rotation effects with characteristic relative maximum and minimum peaks at 180°, 540° 18 
and 360° and 720°, respectively (Fig. 2a). The shape of the oscillation is dependent only on kex (Fig. 19 
2a) and is not affected by changes in concentration (fs), T1w, T2w, and T1s, but only slightly on T2s 20 
(Fig. 2b-f). Fig. 3a gives the simulated and the experimental CEST contrast as a function of θ at pH 21 
of 6.7, 37°C, showing a good correspondence between expected and measured CEST contrast values. 22 
The experimental RPA values measured by ratioing CEST contrasts at 180°/360° at four different pH 23 
values are close to the simulated values (Fig. 3b, Bavg_power of 1μT and dc of 50%). To mimic in vivo 24 
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conditions, iodixanol was dissolved in human serum and the measured RPA curve showed marked 1 
pH dependence even in presence of other exchangeable protons (Fig. 3c). 2 
Fig. 4a reports the observed CEST contrast at 4.3 ppm as a function of flip angle with a Bavg_power of 3 
2 μT and dc 50% (T=21°C, B0=7T) for several pH values, showing the expected angular signal 4 
dependence that oscillates as cos(θ) with a maximum close to 180°. The shape and the magnitude of 5 
the resulting CEST contrast oscillation depend on the proton exchange rate kex. Being kex base-6 
catalyzed, for increasing pH values an increase of the CEST effect is observed. In addition to kex, the 7 
oscillation is also dependent on Bavg power and on the applied duty cycle. In fact, the same angular 8 
dependence was observed upon decreasing the irradiation power to 1 μT (Fig. 4c), keeping constant 9 
the dc to 50%, although the observed CEST contrast appears significantly reduced for all the 10 
investigated pH values. When the pulsed sequence was applied with a dc of 30%, an increase in the 11 
contrast was observed if compared to dc of 50% and the same irradiation Bavg  power (Fig. 4b and 4d). 12 
The Z-spectra generated with a pulsed CEST irradiation scheme for 40 mM iodixanol solutions 13 
titrated in the pH range 5.5-7.9 are shown in Fig. S2. The calculated CEST contrast angular 14 
dependence is shown in Fig. 5. A similar oscillating shape is obtained as a function of the flip angle 15 
even at higher temperature, hence higher exchange rates, and the CEST contrast magnitude is strongly 16 
pH-dependent. A decrease of the irradiation Bavg  power from 2 μT to 0.5 μT corresponds to a marked 17 
reduction of the CEST contrast effect (Fig. 5a, 5c and 5d). When exploiting a dc of 30% a similar 18 
angular dependence of the CEST contrast was measured (Fig. 5b). 19 
The proposed ratiometric approach relies on the ratioing of the relative intensities at different flip 20 
angles as a function of pH (Fig. 6). By ratioing the ST effects observed at flip angles of 180° and 21 
360°, with a constant Bavg power of 1 μT, RPA (averaged over a ROI placed on each sample) showed a 22 
good pH response for pH values from 6.0 to 7.4 (Fig. 6a). Moreover, RPA values calculated upon 23 
using a Bavg power of 0.5 μT yielded an analogous pH response. Good pH sensitivity was obtained also 24 
from RF flip angles of 180° and 720° at both the Bavg power of 1 μT and 0.5 μT (Fig. 6b). Since the 25 
capability to measure accurately pH values is dependent on both the attainable CEST contrast as well 26 
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as on the pH responsiveness, a Bavg power of 1 μT and a dc of 50% were chosen, since higher Bavg power 1 
(2 μT) provided lower pH responsiveness (Fig. S3), whereas dc of 30% provided lower CEST contrast 2 
(Fig. 5b). 3 
Using the relationship between RPA values and experimental pH determined from Fig. 6, pixel-wise 4 
pH maps were derived for the pH phantoms (Fig. 7e with flip angles 180°/360° and Fig. 7f with 5 
180°/720°). Calculated pH values from the obtained maps are plotted as a function of pH-meter 6 
measurements (Fig. 7g and 7h). The observed good correlation (R2 = 0.998, P<0.0001 and R2 = 0.996, 7 
P<0.001, respectively) attests the accuracy of the RPA-based interpolation vs pH. 8 
To demonstrate the concentration independence of the method, a series of phantoms at different 9 
iodixanol concentrations (in the range 2.5-40 mM) were prepared, with pH titrated 7.2. The RPA 10 
values were observed to be constant when ratioing the ST contrast at the two flip angles of 180° and 11 
360° (Fig. 8a, slope = 0.0026 and 0.0011 for Bavg power of 1 and 0.5 μT, respectively). A robust stability 12 
as a function of concentration was obtained also when ratioing the ST contrast obtained at the two 13 
flip angles of 180° and 720° (Fig. 8b, slope = -0.0011 and -0.0008 for 1 and 0.5 μT, respectively). 14 
Only at 2.5 mM iodixanol concentration the measured CEST contrast was not enough for the 15 
calculation of the RPA value. These data demonstrate that this ratiometric approach can measure pH 16 
despite a substantial difference in iodixanol concentration, with all regression slopes not significantly 17 
different from zero. 18 
 19 
4. Discussion 20 
In this study, we report a new ratiometric approach for pH determination based on the transfer of the 21 
oscillation of the solute magnetization to the bulk water signal by applying a pulsed-CEST sequence. 22 
In contrast to the approach of using endogenous amide groups as investigated by Gochberg and 23 
colleagues [55], herein we exploit an exogenous molecule that can potentially provide multiple 24 
information related to the extracellular pH and to its extravasation, hence tissue perfusion [59, 62]. 25 
R1.8 
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Most of the ratiometric approaches for MRI pH mapping have been applied to DIACEST agents (e.g. 1 
iopamidol, iopromide, iobitridol) with relatively fast exchange rates (ca. 1-3 KHz at pH 7.4) for 2 
exploiting higher CEST contrast and efficiency upon a continuous wave RF irradiation [59]. Within 3 
this approach, one may broaden the investigation to exogenous molecules possessing even slower 4 
exchange rates, an exclusive field that was limited to endogenous mobile proteins and peptides. 5 
Moreover, a low-power pulsed saturation scheme can generate CEST signal, thus facilitating clinical 6 
translation [63-65]. 7 
The pulsed-CEST contrast curves of iodixanol as a function of pH showed similar characteristic 8 
feature points at 180°/360°/540° and 720° in comparison to endogenous amide groups. On the 9 
contrary, the CEST contrast ratio calculated from different flip angles showed a different relationship 10 
with kex between endogenous and iodixanol-derived amide protons. In fact, the CEST contrast ratio 11 
calculated at three θ values for the endogenous amide groups (dubbed CCR in [55]) showed a 12 
monotonic function that increases for slow exchange rates with a Bavg power of 1.0 μT and then 13 
decreases for higher exchange rate. In contrast, with iodixanol we observed only a constant decrease 14 
of our ratiometric index (RPA, calculated as the ratio at two different flip angles) at all the investigated 15 
pH values. A similar relationship was observed also when exploiting the same CCR metric approach 16 
for the iodixanol data (Fig. S4), therefore this behavior is likely dependent on the higher exchange 17 
regime of iodixanol amide protons in comparison to the endogenous ones.  18 
The pH relationship of the ratiometric index was found to be dependent on the applied Bavg power and 19 
duty cycle, therefore a Bavg power of 1.0 μT and a duty cycle of 50% were chosen, which gives good 20 
pH sensitivity. In addition, the proposed ratiometric RPA index displays robust solute concentration 21 
independence in the investigated pH, Bavg power and θ values. 22 
Several papers have recognized the advantages of exploiting the ratiometric approach to remove the 23 
concentration term. In particular, CEST-MRI pH sensing agents need to rule out the concentration 24 
term for an accurate measurement of the pH values. Since Ward and Balaban seminal work, only 25 
molecules possessing multiple chemical exchange sites with different frequencies offsets have been 26 
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considered as CEST-based pH sensing agents [66]. This approach was applied for both DIACEST 1 
and PARACEST molecules obeying to the conditions of multiple proton pools, such as iopamidol 2 
and Yb-HPDO3A for assessing pH in several tissues [67-69]. Remarkably, an expansion of this 3 
approach has been obtained based on the irradiation of a single exchanging pool at different RF 4 
saturation powers, hence potentially transforming every CEST molecule into a pH responsive contrast 5 
agent [41, 70]. Notably, the pH-dependence of the chemical shift of a single water exchange CEST 6 
peak has been proposed as a novel pH-imaging approach following a PARACEST agent 7 
administration [71, 72]. While all these methods used long duration and/or high power CW saturation 8 
scheme, the herein reported approach is based on a pulsed CEST sequence that is easily translatable 9 
to clinical MRI scanners owing to the reduced SAR limitation and amplifier restriction due to shorter 10 
pulse duration. In addition, in contrast to the ratiometric approach based on different B1 power levels, 11 
we propose a completely new ratiometric index with a constant Bavg power by varying the irradiation 12 
flip angle θ. The proposed ratiometric method requires only one exchanging pool and it covers a 13 
broad pH range, similar to that achieved with conventional ratiometric pH MRI approaches. The pH 14 
sensitivity index ΔRpH, measured as the difference of the ratiometric index between pH values of 6.0 15 
and 7.4, was found to be between 1.4-1.7 (with Bavg power of 0.5-1.0 µT and dc 50%), slightly lower 16 
than those attainable with the iopamidol- or iopromide-based ratiometric approaches (ΔRpH = 2.8 and 17 
2.7 for iopamidol and iopromide, respectively), but higher to that attainable with the Yb-HPDO3A 18 
PARACEST agent (ΔRpH = 1.1) [41]. Furthermore, the present method, described in this paper using 19 
a x-ray agent characterized by only one mobile amide proton pool, may be applied as well in the 20 
presence of two exchangeable pools (as in the case of iopamidol), with the advantage of a double 21 
independent estimation of pH and thus, in principle, of a higher reliability. More importantly, 22 
radiographic agents, owing to their high safety profile, have already been demonstrated for assessing 23 
pH values at clinical level [73, 74]. 24 
Ratiometric approaches usually require multiple full Z-spectra acquisition that results in longer 25 
overall acquisition time than single acquisition and could be more prone to motion artifacts, although 26 
R2.11 
13 
 
fast acquisition approaches have already been developed [75-77]. Conversely, the proposed approach 1 
can quantify the CEST contrast by the irradiation at only two flip angles, hence resulting in shorter 2 
acquisition times. 3 
The proposed approach relies on irradiation train pulses at different θ, hence B1 inhomogeneities may 4 
affect the accuracy of this procedure, but others have shown that the ratiometric approach is relative 5 
robust to B1 errors [55]  and B1 inhomogeneities are not an issue at animal scanners. On the other 6 
hand, in whole-body-scanners severe B1 inhomogeneities may appear with fluctuations up to +-50% 7 
[78]. However current developments in interpolation approaches of repeated scans with different 8 
effective B1 and in parallel transmission techniques will also allow mitigation of B1 inhomogeneities 9 
in the near future and make the presented approach also translatable in the high field imaging in 10 
humans [78, 79]. 11 
There are some remaining challenges that will be addressed to improve the proposed procedure. First, 12 
accurate pH responsiveness  requires a  suitable local concentration  of  the  detected CEST contrast 13 
agent; in particular, obtained preliminary results seem to indicate that iodixanol should accumulate 14 
in the organ of interest with concentrations higher than 2.5 mM. However, previous studies have 15 
shown that this is feasible even in the tumor extracellular space with an average accumulation of 5-8 16 
mM [59]. In addition, future studies should be addressed to validate in vivo the proposed new 17 
ratiometric approach for assessing pH. 18 
 19 
5. Conclusions 20 
In summary, this study provides a new ratiometric approach for exogenous agents based on a pulsed 21 
CEST scheme with multiple irradiation flip angles and constant B1 amplitude that extends the field 22 
of application for CEST-based pH imaging. 23 
 24 
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 1 
Figure 1 Chemical structure of the radiographic agent iodixanol. 2 
 3 
Figure 2 Simulated CEST contrast (ST%) as a function of θ showing the oscillation component for 4 
iodixanol when irradiated with a pulsed gaussian train with constant Bavg power of 2µT and dc 50%. 5 
Simulations were performed for different kex (a), fs (b), T1w (c), T2w (d), T1s (e), T2s (f) by using a 6 
three-pool model. In panels (b-f) the normalized CEST contrast (normalized ST%) is the CEST 7 
contrast (ST%) normalized at θ = 900°.  8 
 9 
Figure 3 (a) Simulated (solid line) and experimental (circle) CEST contrast for a 40 mM iodixanol 10 
solution as a function of θ (θ = 45°, 90°, 135°, 180°, 225°, 270°, 315°, 360°, 405°, 450°, 540°, 630°, 11 
720°, 810°, 900°,  kex =160 Hz, Bavg power 2 μT, dc 50%, B0 7T, 37°C). (b) Simulated (square) and 12 
experimental (circle) ratiometric value (RPA) calculated for different titrated pH values (B0=7T, 13 
Bavg power 1 μT and dc 50%). (c) Calculated RPA curve with iodixanol dissolved in human plasma 14 
(B0=7T, Bavg power 1 μT and dc 50%, 37°C). 15 
 16 
Figure 4 Plot of CEST contrast as a function of θ at T=21°C for a 40 mM iodixanol solution at 17 
several pH values in the range 5.5-7.9 for different experimental conditions: (a) Bavg power 2 μT and 18 
dc 50%; (b) Bavg power 2 μT and dc 30%; (c) Bavg power 1 μT and dc 50% and (d) Bavg power 1 μT and dc 19 
30% with a total irradiation time of 5 s (B0 = 7T; T=21°C). 20 
 21 
Figure 5 Plot of CEST contrast as a function of θ at 37°C for a 40 mM iodixanol solution at several 22 
pH values in the range 5.5-7.9 for different experimental conditions: (a) Bavg power 2 μT and dc 50%; 23 
(b) Bavg power 2 μT and dc 30%; (c) Bavg power 1 μT and dc 50% and (d) Bavg power 0.5 μT and dc 50% 24 
with a total irradiation time of 5 s (B0 = 7T; T=37°C) 25 
 26 
20 
 
Figure 6 CEST contrast ratiometric RPA values as a function of pH for Bavg power of 1 μT and 0.5 1 
μT and dc 50% with θ ratio of (a) 180°/360° and (b) of 180°/720° (B0 = 7T; T=37°C; total 2 
irradiation time of 5 s). 3 
  4 
Figure 7 T2w image of phantom containing 40 mM iodixanol adjusted to the indicated pH values 5 
(a), ST maps obtained after pulsed irradiation with θ values of 180° (b), 360° (c) and 720° (d) and 6 
corresponding pH maps as determined by the RPA approach by ratioing (e) 180°/360° and (f) 7 
180°/720° θ values with Bavg power of 1 μT and dc 50%.  Calculated pH vs experimental pH by 8 
ratioing (g) 180°/360° θ values (R2 = 0.998, P<0.001) and (h) 180°/720° θ values (R2 = 0.996, 9 
P<0.0001).  10 
 11 
Figure 8 Regression analysis between RPA ratiometric values and iodixanol concentration (range 12 
2.5-40 mM) with Bavg power of 1 μT and 0.5 μT and dc 50%: by ratioing (a) 180°/360° θ values and 13 
(b) 180°/720° θ values (B0 = 7T; T=37°C; total irradiation time of 5 s). All regression lines have 14 
slopes not significantly different from zero. 15 
 16 
 17 
 18 
